Is Mortality a Useful Primary End Point for Critical Care Trials?

Area of Science:

• Critical Care Medicine
• Clinical Trial Design
• Biostatistics

Background:

• Mortality is a traditional primary endpoint in critical care randomized controlled trials (RCTs).
• A growing number of critical care RCTs using mortality endpoints have yielded neutral results.
• This trend raises questions about the suitability and potential biases of mortality as a primary outcome measure.

Purpose of the Study:

• To investigate the reasons behind the high rate of neutral results in critical care RCTs with mortality endpoints.
• To explore potential biases inherent in using mortality as a primary outcome.
• To advocate for the consideration of alternative endpoints that may better reflect therapeutic effects and patient importance in the ICU.

Main Methods:

• Review of recent critical care randomized controlled trials with mortality as a primary outcome.
• Exploration of statistical and clinical factors influencing trial results.
• Discussion of the patient-importance of mortality as a binary outcome in intensive care unit (ICU) settings.

Main Results:

• Several factors contribute to the preponderance of neutral trials when mortality is the primary endpoint.
• The use of mortality as a binary outcome may introduce biases, leading to underestimation of treatment effects.
• Alternative endpoints may be more sensitive to therapeutic interventions and more aligned with patient values.

Conclusions:

• The reliance on mortality as a primary endpoint in critical care RCTs may be contributing to a high rate of inconclusive studies.
• Re-evaluating the choice of primary endpoints is crucial for improving the efficiency and interpretability of critical care research.
• Considering patient-important alternative outcomes can lead to more meaningful and actionable trial results.